[(3aR,8bS)-4,8b-dimethyl-3-[2-(4-propan-2-ylphenyl)ethyl]-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-(4-propan-2-ylphenyl)carbamate | 1221447-31-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: [(3aR,8bS)-4,8b-dimethyl-3-[2-(4-propan-2-ylphenyl)ethyl]-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-(4-propan-2-ylphenyl)carbamate
• CAS: 1221447-31-9
• 化学式: C₃₃H₄₁N₃O₂
• 分子量: 511.707
• InChiKey: QPCSBYIUPJATOY-WEZIJMHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  38
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  44.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (3aS,8aR)-1-(4-isopropylphenethyl)-3a,8-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-ol 、 4-异丙基苯异氰酸酯 在 sodium 作用下， 以 乙醚 为溶剂， 反应 0.08h， 生成 [(3aR,8bS)-4,8b-dimethyl-3-[2-(4-propan-2-ylphenyl)ethyl]-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-(4-propan-2-ylphenyl)carbamate
  参考文献：
  名称：

  Design, synthesis, evaluation and QSAR analysis of N1-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors

  摘要：

  We synthesized a series of N-1-substituted norcymserine derivatives 7a-p and evaluated their anti-cholinesterase activities. In vitro evaluation showed that the pyridinylethyl derivatives 7m-o and the piperidinylethyl derivative 7p improved the anti-butyrylcholinesterase activity by approximately threefold compared to N-1-phenethylnorcymserine (PEC, 2). A quantitative structure-activity relationship (QSAR) study indicated that logS might be a key feature of the improved compounds. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.01.057

文献信息

• Design, synthesis, evaluation and QSAR analysis of N1-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors
  作者：Jun Takahashi、Ichiro Hijikuro、Takeshi Kihara、Modachur G. Murugesh、Shinichiro Fuse、Ryo Kunimoto、Yoshinori Tsumura、Akinori Akaike、Tetsuhiro Niidome、Yasushi Okuno、Takashi Takahashi、Hachiro Sugimoto

  DOI：10.1016/j.bmcl.2010.01.057

  日期：2010.3

  We synthesized a series of N-1-substituted norcymserine derivatives 7a-p and evaluated their anti-cholinesterase activities. In vitro evaluation showed that the pyridinylethyl derivatives 7m-o and the piperidinylethyl derivative 7p improved the anti-butyrylcholinesterase activity by approximately threefold compared to N-1-phenethylnorcymserine (PEC, 2). A quantitative structure-activity relationship (QSAR) study indicated that logS might be a key feature of the improved compounds. (C) 2010 Elsevier Ltd. All rights reserved.